Navigation Links
Development of Broadly-protective HIV Vaccine is Possible

The creation of a vaccine to protect against the myriad strains of the human immunodeficiency virus (HIV) may be possible, according to a new study conducted at the Uniformed Services University of the Health Sciences (USU).

Since HIV is extremely variable, its prevention requires a vaccine effective enough to stimulate the body to produce cross-reactive antibodies that can neutralise multiple viral strains.

The latest study shows that the goal of induction of truly broad-spectrum neutralising antibodies may be achieved.

During the study, USU Professors Dr. Gerald Quinnan, Jr. and Dr. and Christopher Broder attempted to elicit cross-reactive antibodies in an animal model by immunising with a particular HIV-1 surface protein, namely R2 gp140, and an immune response-boosting component.

The researchers tested antibodies generated by the immunisations to determine their effectiveness in neutralising the infectivity of a variety of HIV-1 strains.

It was seen that the antibodies were capable of neutralising all 48 strains of HIV-1 tested.

The results are encouraging for vaccine development, as they show that it is possible to elicit a broad-spectrum antibody response.

The study entitled Extensively Cross-Reactive Anti-HIV-1 Neutralizing Antibodies Induced by gp140 Immunization has been published in the Proceedings of the National Academy of Sciences.


'"/>




Page: 1

Related medicine news :

1. Developmental, neurologic problems common in extremely preterm infants
2. Development of AIDS vaccine -- Chiron Corp in talks with four Indian cos
3. Missing Protein In Cancer Development
4. Tomatoes Might Inhibit the Development Of Prostate Cancer
5. Pollution Found To Impair Lung Development
6. Treating Depression In Children Could Lead To Poor Bone Development
7. Developmental Origins of Polycystic Ovarian Syndrome
8. Sleep Not Critical For Early Brain Development Of Baby Dolphins
9. ‘Loud Noise’ Research may help in Development of Prosthetics for Eldery
10. Stop Watching TV: Toddler Development Affected
11. Vitamin Supplements During Pregnancy to Boost Fetal Development
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... ... January 19, 2017 , ... ... expansion and facility enhancement of their 503A compounding pharmacy located in Ocala, Florida. ... demand of physicians and patients throughout the United States for high-quality human ...
(Date:1/19/2017)... ... January 19, 2017 , ... Remote ... recently unveiled impressive transportable capabilities with their iMedHD2™ Portable Teleultrasound System. ... to RMT technology that delivers HD, dynamic, streaming ultrasound images and video to ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... provided a new $11,250,000 senior credit facility to Sunrise, Florida-based Management Health Systems, ... were used to facilitate a recapitalization of MedPro led by Harren Equity Partners. ...
(Date:1/19/2017)... CA (PRWEB) , ... January 19, 2017 , ... ... Tranquility acoustic and privacy panel system. , The Tranquility privacy panel system ... a collaborative office environment. Tranquility panels help reduce noise and provide the visual ...
(Date:1/19/2017)... ... ... Tribble Insurance Agency, a family owned and operated firm offering asset protection ... to honor Chad Phillip Dermyer, a local police trooper who was shot and killed ... fellow officers were conducting routine stops of suspects when one of them, a violent ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , January 19, 2017 According to a ... cryotherapy is set to witness a CAGR of 6.5% during the ... will continue to be the leading market for cryotherapy ... ... are emphasizing on ensuring affordable and adequate supply of gas in ...
(Date:1/19/2017)... , January 19, 2017 ... ; European Oncology & Haematology, 2016;12(Suppl 2):3-8; ... ... Published recently in a ... peer-reviewed journal from touchONCOLOGY, an article by ...
(Date:1/19/2017)... January 19, 2017 Shire plc ... the U.S. Food and Drug Administration (FDA) has acknowledged ... Drug Application (NDA) for SHP465, a long-acting, triple-bead, mixed ... potential once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA ... June 20, 2017, the designated Prescription Drug User Fee ...
Breaking Medicine Technology: